Purpose: This study prepared three structurally related zinc-dipicolylamine (ZnDPA) In-labeled radiotracers were prepared with a radiopurity of 990 %. The biodistribution studies showed that the two monovalent tracers were cleared from the body through the liver and kidney, with retained percentage injected dose for all organs of G8 % at 20 h and infected leg target to non-target ratio (T/NT) ratio of ≤3.0. Clearance of the divalent tracer from the bloodstream was slower and primarily through the liver, with a retained percentage injected dose for all organs G37 % at 20 h and T/NT ratio rising to 6.2 after 20 h. The SPECT/CT imaging indicated the same large difference in tracer pharmacokinetics and higher accumulation of the divalent tracer at the site of infection.
Introduction
A ccurate and rapid diagnosis of bacterial infection is one of the grand challenges of modern global health care [1] [2] [3] . Early detection is crucial for patients that are immunosuppressed as a result of cancer treatment, transplantation, or an autoimmune disease because of their increased vulnerability to relatively nonvirulent microorganisms [4] . The increasing use of prosthetic devices such as artificial heart valves, gastric bands, and synthetic joints has also provided niches for bacterial colonization [5, 6] . At present, conventional microbiologybased diagnostic methods remain a clinical standard of care [7] . They typically involve examination and culture of samples taken from suspicious sites. These procedures are laborious and insensitive, and the results are often acquired too late to guide therapeutic decision making [8, 9] . It is recognized that improved noninvasive imaging technology will greatly facilitate the process of infection diagnosis [1] [2] [3] .
Infection imaging methods can be divided into two major groups: indirect procedures that report the immune response to infection and molecular probe strategies that directly target the bacterial cells. The first approach focuses on host inflammatory biomarkers such as increased blood flow, vascular permeability, and the infiltration of white blood cells (WBCs). Imaging methods include single-photon emission tomography and computed tomography (SPECT/ CT) detection of either [
67 Ga]citrate or radiolabeled WBCs [9] . In addition, the positron emission tomography (PET) tracer 2-deoxy-2-[
18 F]fluoro-D-glucose is known to accumulate in activated WBCs that are associated with infection [10] . A drawback with these immune-based methods is the inability to readily delineate sterile inflammation from bacterial colonization. Additionally, the methods are contingent on a functional immune response and thus, is not applicable for immunosuppressed patients.
Radiolabeled tracers that directly target the bacterial cells are inherently attractive for infection imaging. Various unique structural and functional bacterial targets have been investigated such as the bacterial cell wall proteins, bacteria-specific enzymes, and the DNA synthesis and translational machinery. High-affinity molecular probes have been explored including radiolabeled antibiotics, antibodies, oligomers, peptides, and bacteriophages [11] [12] [13] [14] . Despite considerable effort, significant challenges remain for broad clinical translation of these bacteria binding systems. Recently, there has been a trend towards imaging probes that accumulate inside bacteria. These probes are fluorescent or radiolabeled biomolecules that only bacteria can absorb and metabolize, and they include derivatives of maltodextrin and uracil [15, 16] . While these bacteria accumulation strategies have shown preliminary success, more studies are required to test imaging performance with biofilms and bacteria that are metabolically dormant.
A significant structural difference between bacteria and mammalian host cells is the identity and associated electrostatic charge of the amphiphilic molecules within the cell envelope. Nearly all bacterial membranes possess a negative surface charge resulting from high fractions of the abundant anionic phospholipids and related amphiphiles. For example, the plasma membrane of Gram positive Streptococcus pyogenes (the bacterial system employed in this present study) contains significant fractions of the anionic phospholipids phosphatidylglycerol (∼20 %) and cardiolipin (∼5 %) [17] . We have discovered that synthetic zinc-dipicolylamine (ZnDPA) coordination complexes have high affinity for anionic cell membranes, and they can selectively target bacterial cells over the zwitterionic membrane surfaces of healthy mammalian cells [18] [19] [20] [21] [22] [23] [24] . Fluorescent ZnDPA probes have been shown to stain Gram positive and Gram negative bacteria and near-infrared fluorescent versions are effective for in vivo imaging of infection in rodents [19, 22] . The clinical utility of optical imaging probes is limited and there is a need to synthesize and evaluate radiolabeled ZnDPA tracers for infection imaging. To date, a preliminary SPECT imaging study of a nanoparticle construct, comprised of streptavidin protein decorated with biotinylated ZnDPA and chelated 111 In, has been shown to selectively target infection over sterile inflammation in a mouse model [25] . Small molecule versions of ZnDPA tracers with 99m Tc and 18 F labels have been prepared but not yet evaluated for infection imaging [26] [27] [28] . This present report describes a mouse biodistribution and preliminary SPECT imaging study that evaluates three, low molecular weight ZnDPA tracers labeled with 111 In. We find that all three tracers selectively accumulate at the site of a clinically relevant S. pyogenes leg infection. The highest target selectivity, observed with a divalent tracer equipped with two zincdipicolylamine targeting units, compares quite favorably with the in vivo imaging selectivities reported for other nuclear tracers that target bacterial cell surfaces. 
Materials and Methods

Radiolabeling of ZnDPA-Chelator Conjugates
Synthesis and characterization of the three precursor DPA-chelator conjugates is described in the Electronic Supplementary Material. In each case, the Zn 2+ complex was formed by combining methanol solutions of the precursor DPA-chelator conjugate and zinc nitrate in a 2.2:1 M ratio and shaking the solution for 45 min at room temperature. The solvent was evaporated to give the desired ZnDPA-chelator conjugate with no further purification. Radiolabeling was achieved by mixing an appropriate aliquot of 111 InCl 3 from a stock solution of 2 mCi/10 μl in 0.05-M HCl (purchased from PerkinElmer) and an equal volume of sodium acetate (0.5 M; pH 5.7) and incubating at 25°C for 30 min. The solution was then mixed with one of the three ZnDPA-chelator conjugates in sodium acetate (0.1 M; pH 6.1) and incubated for 1-h (DTPA conjugates) or 3 h (DOTA conjugate) at 50°C. The specific activity of each tracer for the biodistribution and SPECT imaging experiments was kept close to 3 μCi/μg.
The radiochemical purity was determined using reverse-phase HPLC system equipped with a 515 pump, an in-line dual UV/ radioactivity detector under the control of Millennium 32 software (Waters, Milford, MA). A Jupiter C18 column (90 Å pore size, 250 mm×4.6 mm) was employed with a buffered mobile phase system consisting of mobile phase A (99.9 % water, 0.1 % TFA, pH 6.7) and mobile phase B (99.9 % acetonitrile, 0.1 % TFA) at a flow rate of 1.0 ml/min at room temperature. A baseline of 5 min at 90 % mobile phase A and 10 % mobile phase B was followed by a linear gradient to 10 % mobile phase A and 90 % mobile phase B in 30 min. The retention times of the 111 In-labeled tracers matched the retention times of cold versions. The level of radioactivity in the HPLC elute was monitored by the in-line radioactivity detector and the percent 111 In for each peak was calculated from the integrated area.
Fluorescence Microscopy of Streptococcus Pyogenes
S. Pyogenes (ATCC 19615) was cultured in Luria broth (LB) containing no antibiotic after transfer from a preserved sample stored at 4°C. Cells were allowed to grow overnight by incubating at 37°C. Samples of 10 7 colony forming units (CFU) were centrifuged at 10,000 rpm for 5 min. Growth media was removed, and the cells resuspended in 10-mM HEPES buffer (137-mM NaCl, 3.2-mM KCl, pH 7.4). Cells were then treated with 50 nmol of PSVue643 (purchased from Molecular Targeting Technologies Inc.) and the mixture was incubated in the dark for 15 min at room temperature. After centrifugation at 10,000 rpm for 5 min, the media was discarded and the pellet resuspended in 10-mM HEPES buffer with vortexing. The stained cells were rinsed with HEPES buffer by repeating the centrifugation/resuspension cycle. Fluorescence microscopy was conducted on a Nikon Eclipse TE-2000 U epifluorescence microscope equipped with Cy5 (exciter: HQ620/60X, dichroic: 660LP, emitter: HQ700/75 m) filter. Images were acquired using Nikon RL software (v 6.2 Molecular Devices, Sunnyvale, CA) and a Photometrics 512 B black and white digital camera (×100) at 150-ms acquisition time.
Membrane Association Studies Using Eu
3+ -labeled ZnDPA Tracers
The preparation of vesicles composed of POPC:Cholesterol:2,3-Naphthalimide:DPPE-PEG 2000 in the molar ratio of 72:10:10:8 and synthesis of photoactive Eu-labeled ZnDPA tracers ( Fig. 1) is described in the Electronic Supplementary Material. The titration experiment added aliquots of Eu-labeled ZnDPA tracer to separate solutions of vesicles (100-μM final concentration) in HEPES buffer (10-mM HEPES, 137-mM NaCl, 3.2-mM KCl, pH 7.4) at 25°C. After waiting 60 s for equilibration to occur, energy transfer from 
Serum Protein Association Studies Using Eulabeled ZnDPA Tracers
Qualitative equilibrium dialysis assays were used to measure tracer affinity to serum albumin. Experiments employed an equilibrium dialysis cell consisting of two compartments, "source" and "receiver," separated by a 10,000 molecular weight cutoff membrane that was impermeable to albumin proteins. Briefly, either TES buffer (10-mM TES, 145-mM NaCl, pH 7.4) or bovine serum albumin (80 %) was added to the receiver compartment (750 μl) of the equilibrium dialysis apparatus while a Eu-labeled ZnDPA tracer (20 μM) in TES buffer (10-mM TES, 145-mM NaCl, pH 7.4) was added to the source compartment (750 μl). The system was allowed to equilibrate by shaking at 180 rpm and 37°C for 24 h. The amount of ZnDPA tracer in each compartment was determined using a colorimetric indicator, NO 2 -PAPS, as previously described [29] . Control experiments confirmed that an unbiased dialysis equilibrium occurred in the absence of serum albumin.
Radiotracer Biodistribution in Mouse Leg Infection Model
All animal studies were performed with the approval of the UMMS Institutional Animal Care and Use Committee. The following biodistribution experiment was conducted with each of the three radiolabeled ZnDPA tracers. Two cohorts of healthy CD-1 nude mice (each cohort n=4 males 20-25 g, Charles River) were given a bolus injection of S. Pyogenes (5×10 8 CFU in 100 μl of LB growth media, determined by plating of serial dilutions on agar plates) injected into the target (T) muscles that overlay the tibia bone in the right posterior leg. The same volume of saline was injected into the contralateral leg which was treated as the non-target site (NT). The mice were allowed to recover for 3 h, before dosing via the tail vein with radiolabeled ZnDPA tracer (∼150 μl, 20 μCi) in saline. After 1 h, one cohort was anesthetized and sacrificed, and the second cohort was sacrificed after 20 h. The organs were excised, weighed, and radioactivity counted using a NaI (T1) automatic gamma counter against a standard of the injectate. The percent injected dose per gram of tissue (%ID/g) was calculated and the target to non-target ratio (T/NT) was determined using the values of percent injected dose per gram of tissue for the infected and normal legs.
SPECT/CT Imaging of Mouse Leg Infection Model
The following imaging experiments were conducted with each of the three radiolabeled ZnDPA tracers using a NanoSPECT/CT (Bioscan, Washington, DC) small animal camera. A bolus of S. Pyogenes (5×10 8 CFU) in 100 μl of LB growth media was injected into the muscles that overlay the right tibia bone of a cohort of healthy CD-1 mice (n=2). As a control, the same volume of saline was injected into the contralateral leg. The mice were allowed to recover for 3 h before intravenous injection with radiolabeled ZnDPA tracer (∼150 μl, 450 μCi) in saline via the tail vein. Each mouse was imaged at approximately 1, 4, and 20 h after tracer injection. In each case, the mice were anesthetized with 1-2 % isoflurane in oxygen and whole body scans were acquired. A CT acquisition, requiring about 4 min, was performed before each SPECT acquisition, at standard frame resolution, 180 projections, 45-kVp tube voltage and 500 ms of exposure time. The SPECT image was acquired with a 256×256 frame size and 24 projections. The time per projection was adjusted to collect approximately 50,000 counts/detector for each projection. For initial scans, this required 50 s/projection (total scan time of 30 min) and was increased to a maximum of 110 s/projection (total scan time of 60 min). The SPECT and CT reconstructions and volume-of-interest analysis of the SPECT acquisitions were performed using InVivoScope 1.43 software (Bioscan, Washington, DC).
Statistical Analysis
The Student's t test was used for significance determination where indicated.
Results
Tracer Synthesis
Shown in Fig. 1 are the three sets of ZnDPA tracers that were prepared and studied. The cold Eu-labeled structures were prepared for two reasons: (a) to confirm that the DOTA and DTPA chelators within the precursor DPA conjugates were vacant and available for heavy metal chelation and (b) to enable the membrane association assay described below. The three 111 In-labeled ZnDPA tracers were prepared by sequentially converting the precursor DPA-chelator conjugates into Zn 2+ complexes and then into 111 In 3+ chelates. A previous titration study of a related DPA-chelator conjugate proved that the Zn 2+ complexation is specific for the DPA units and the heavy metal cations occupy the attached DTPA or DOTA chelator [30] . Figure 2 shows reverse-phase HPLC radiochromatograms of the three 111 In labeled ZnDPA tracers. The retention time and radiopurity for each tracer 
Fluorescence Microscopy of Streptococcus Pyogenes
Targeting of a low molecular weight, ZnDPA tracer to S. Pyogenes cells was verified using fluorescence microscopy. Figure 3 shows images of intensely stained S. Pyogenes cells after treatment with PSVue643, a commercially available deep-red, fluorescent ZnDPA tracer [31] .
Membrane and Serum Association Studies Using Eu-labeled Tracers
The propensity for lipophilic association of the ZnDPA tracers with biological surfaces was assessed in two ways. One was a membrane association assay using vesicle membranes composed of POPC:Cholesterol:2,3-Naphthalimide:DPPE-PEG 2000 in the molar ratio of 72:10:10:8. The large fraction of zwitterionic POPC and cholesterol mimics the plasma membrane composition of healthy mammalian cells. The small fraction of DPPE-PEG 2000 was included to inhibit any vesicle crosslinking, a phenomena that was observed when anionic vesicles (mimics of bacterial cell membranes) were treated with the divalent tracer. The assay monitored energy transfer from membrane-bound photosensitizer (2,3-naphthalimide) to any Eu-labeled ZnDPA tracer that associated with the vesicle surface (Scheme S1) [32] . The titration plots in Fig. 4 reflect the relative membrane affinity of the four Eu-labeled complexes in Fig. 1 [33, 34] . Furthermore, attachment of a second ZnDPA unit increases the molecular hydrophilicity.
The relative affinity of the three Eu-labeled tracers for serum proteins was determined using an equilibrium dialysis assay. The results are presented in Fig. 5 111 In labeled versions of these monovalent tracers exhibited very similar mouse biodistribution profiles (see below). Apparently, the difference in albumin affinity does not translate into altered pharmacokinetics.
In Tracer Biodistribution in Mouse Leg Infection Model
The biodistribution of each radiolabeled ZnDPA tracer in the mouse infection model was determined at 1 and 20 h after tracer dosage. For each tracer, two separate cohorts of healthy CD-1 mice (n=4) were inoculated with S. Pyogenes (5×10 8 CFU) in the target posterior leg (T) and saline in the contralateral normal leg (NT). This bacterial burden did not produce externally visible evidence of swelling or redness-the mice looked and behaved as if uninfected. Three hours later, both cohorts were dosed intravenously In]DTPA, was slower and there was higher accumulation at the site of infection. The retained percentage injected dose by all organs was 62 % at 1 h and 37 % at 20 h, with the vast majority of the retained dose in the liver. The T/NT was 2.8 at 1 h and 6.2 at 20 h.
SPECT/CT Imaging of Mouse Leg Infection Model
The SPECT/CT imaging studies employed a 22-fold higher tracer dose, but the same general tracer biodistribution trends were observed. Analysis of the SPECT data enabled determination of the percent injected dose remaining in the body of the infected mice at three different time points after tracer injection ( Table 2 ). The highest T/NT ratio (4.0) observed by SPECT imaging was obtained using Bis(ZnDPA)-[ 111 In]DTPA and that was measured at 20 h after tracer dosing. Montages of infected mice, dosed with each of the three tracers, are provided in the Electronic Supplementary Material (Fig. S2) .
Discussion
Our previous studies of fluorescent ZnDPA probes has shown that they exhibit highly selective targeting of Gram positive and Gram negative bacteria in the presence of healthy mammalian cells [18] [19] [20] [21] [22] [23] [24] . Furthermore, animal imaging studies have shown that ZnDPA probes accumulate in sites of bacterial infection and not in sites of sterile inflammation [24, 25] . Histological analyses of the infected tissue indicate high levels of probe localization with the bacterial cells [22] . Since ZnDPA probes also target the anionic surfaces of dead/dying mammalian cells, it is possible that probe accumulation in sites of chronic infection 
D.R. Rice et al.: Evaluation of [
111 In]-Labeled Zinc-Dipicolylamine Tracersmay also be due to ZnDPA association with dead/dying inflammatory cells or dead/dying host cells that have become infected with bacteria. In other words, the ZnDPA probes could be behaving as a mimic of the cell death probe annexin V [35] . But this is unlikely to be a major targeting process in this present study, since an acute infection model was employed with no visible evidence of host tissue necrosis. S. pyogenes is a clinically relevant bacterial infection that is associated with invasive disease having a high mortality. The infection burden of 10 8 CFU used in our experiments is comparable to the bacterial levels found in clinical Gram positive infections [36] [37] [38] . Previous imaging studies have demonstrated that ZnDPA probes can selectively target S. pyogenes over host tissue in a mouse infection model [25] . Confirmation of direct bacterial cell targeting ability was gained by conducting fluorescence microscopy experiments that imaged cell staining by PSVue643, a deep-red fluorescent ZnDPA probe (Fig. 3) . The three tracer designs in Fig. 1 are amide bond conjugates of ZnDPA targeting groups linked to a chelator that is occupied with a reporting heavy metal cation. Cold Eulabeled versions were prepared and used to measure nonselective association with serum proteins and a vesicle mimic of the mammalian cell plasma membrane [32] . Both sets of assays concluded that the divalent tracer, Bis(ZnDPA)-[Eu]DTPA, is relatively hydrophilic and does not have strong affinity for lipophilic binding sites within proteins or relatively uncharged bilayer membranes.
The three 111 In-labeled tracers in Fig. 1 were prepared in 990 % radiochemical purity. 111 In was employed as the reporter isotope for two reasons: synthetic convenience, and its long half life (∼67 h) which enables longitudinal studies. The two monovalent tracers, ZnDPA-[
111 In]DTPA and ZnDPA-[
111 In]DOTA, allowed a comparative assessment of the effect of chelator structure (DTPA vs DOTA) on biodistribution [33, 34] . The membrane association assay (Fig. 4) indicated that the DOTA analog was slightly more lipophilic, however, the biodistribution data showed that both monovalent tracers cleared equally rapidly through the liver and kidney and the SPECT imaging showed that the T/ NT ratios (≤3.0) peaked within a few hours. These results reflect the relatively modest affinity of the monovalent tracers for the target bacteria cells. In comparison, multivalent ZnDPA probes such as the divalent Bis(ZnDPA)-[ 111 In]DTPA are known to exhibit enhanced bacterial affinity and a propensity to induce bacteria cell agglutination [39] . Clearance of the divalent tracer from the bloodstream was comparatively slow and primarily through the liver with high accumulation at the infection site. This clearance profile differs substantially from the related 111 In-DOTA-biotin/ avidin/biotin-ZnDPA nanoparticle system described by Liu et al. which accumulated strongest in the kidneys and bladder with minimal accumulation at the liver [25] . The T/NT ratio of the divalent probe rose to a value of 6.2 at 20 h. This compares favorably to the reported performance of other bacteria-targeted probes in the literature. For example, the radiolabeled antibiotic 99mTc-pheophorbide-a produced a T/NT ratio of 5.6 for infection in rats [40] . Technetium-99m-labeled ubiquicidin peptide (99mTc-UBI), a cationic human antimicrobial peptide fragment, realized T/ NT ratios between 2 and 3.5 in an infected mouse leg model [41] [42] [43] , and the radiolabeled antibiotic 99mTc-vancomycin produced a T/NT ratio of five in infected rats [44] . The superior bacteria targeting of the divalent tracer was expected based on our earlier work with fluorescent versions and the fact that the SPECT/CT imaging could identify a site of infection that was not obvious by visual external inspection of the living animal is a notable achievement. Furthermore, the resolution of the SPECT/CT image at 20-h post divalent tracer injection was sufficient to reveal the beginning of abscess formation. With immune-competent mice, abscesses are formed as a defensive mechanism to prevent the spread of bacteria to other parts of the body. Abscess visualization has been previously observed with a number of magnetic resonance contrast agents [45] [46] [47] .
The membrane and serum protein association experiments with stable Bis(ZnDPA)-[Eu]DTPA tracer showed that it is more hydrophilic than the two monovalent versions. Thus, the high level of Bis(ZnDPA)-[
111 In]DTPA accumulation in the liver and intestines is not because of enhanced association with blood proteins. Transchelation of the radiolabel by metal scavengers in the bloodstream is also very unlikely since Hnatowich et al. showed that the 111 In transfer rate from DTPA to transferrin is ∼5 %/day [48] . It appears that the slow body clearance and high liver uptake of the divalent tracer is related to its propensity to form cross-linked aggregates with anionic particles and molecules such as bacterial and inflammation cells and the phosphorylated molecular components. The liver is a critical defense component against bacteremia and is known to rapidly sequester large amounts of systemic bacteria [49, 50] . Thus, future imaging studies with next-generation ZnDPA tracers should investigate modified molecular structures that maintain the high affinity for bacterial cells but do not exhibit crosslinking effects. Our recent development of high throughput synthesis and screening methods for nextgeneration ZnDPA membrane recognition units is expected to greatly facilitate this tracer discovery process [29] . The fact that relatively minor structural changes in tracer structure can produce large differences in pharmacokinetic properties suggests that it may be possible to rapidly optimize in vivo imaging performance.
Conclusions
The synthesis of three radiolabeled [
111 In]ZnDPA was achieved with radiopurity 990 %. Biodistribution and SPECT/CT imaging shows that the two monovalent tracers clear relatively rapidly from the mouse body through the liver and kidney with modest selective targeting of the site on leg infection. The divalent tracer exhibited significantly higher targeting to an infection site that otherwise could not be discerned by visual external inspection of the living animal. The high selectivity of the divalent tracer compares quite favorably with the selectivities previously reported for other nuclear imaging tracers that target bacterial cell surfaces.
